Higher expression of SPOP positively correlated with longer survival in TNBC or high-grade breast cancer patients, whereas patients with increased levels of TWIST1 were associated with poor prognosis (Fig. 1G–J). This evidence concerns the gene SPOP and breast carcinoma.